Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| NBTX | PRESS-RELEASE | neutral | 1/10 | Nanobiotix S.A. disclosed its monthly share capital and voting rights as of August 31, 2026, reporting 50,941,528 shares | Sep 22, 2026 |
| BMEA | 424B5 | bearish | 6/10 | Biomea Fusion is conducting a dilutive underwritten public offering of common stock and pre-funded warrants at an undisc | Sep 22, 2026 |
| AYTU | 8-K | bullish | 6/10 | Aytu BioPharma reported fiscal Q4 2026 results with net revenue of $16.1M (+6.4% YoY), driven by $3.9M in EXXUA revenue | Sep 22, 2026 |
| BETRF | SC 13G | neutral | 4/10 | RA Capital Management, L.P. and affiliated entities disclosed a 9.0% passive stake in BetterLife Pharma Inc., holding 55 | Sep 22, 2026 |
| PULM | 425 | neutral | 3/10 | Eos SENOLYTIX announced its CEO will deliver a keynote at the 17th World Congress on Targeting Mitochondria (Oct 21-23, | Sep 22, 2026 |
| BMEA | PRESS-RELEASE | bearish | 5/10 | Biomea Fusion announced an underwritten public offering of common stock and pre-funded warrants, with a 30-day underwrit | Sep 22, 2026 |
| NVS | INST-CLUSTER | mixed | 4/10 | A mixed institutional cluster in NVS for Q2 2026 shows 23 buyers accumulating $427.4M (led by JPMorgan, WCM, and Millenn | Sep 22, 2026 |
| EIKN | INST-CLUSTER | neutral | 3/10 | A bullish institutional cluster formed in EIKN during Q2 2026, with 10 funds adding $61.1M in net new positions (total b | Sep 22, 2026 |
| ELDN | INST-CLUSTER | bullish | 4/10 | A strong institutional accumulation cluster emerged in ELDN during Q2 2026, with 26 buyers adding $16.6M in net new posi | Sep 22, 2026 |
| ELTX | INST-CLUSTER | neutral | 3/10 | An institutional cluster in ELTX shows 7 buyers (net +$1.9M) against 1 seller (-$60K), dominated by mega-passive funds ( | Sep 22, 2026 |
| CTNM | INST-CLUSTER | mixed | 3/10 | Institutional activity in Contineum Therapeutics (CTNM) during Q2 2026 was highly mixed: 17 buyers accumulated $51.4M in | Sep 22, 2026 |
| BTMD | INST-CLUSTER | neutral | 3/10 | Institutional activity in biote Corp. (BTMD) during Q2 2026 was mixed: 9 small buyers accumulated $1.1M in new positions | Sep 22, 2026 |
| CRBP | INST-CLUSTER | mixed | 3/10 | Institutional activity in CRBP during Q2 2026 was mixed: 17 buyers added $5.4M in new positions (led by passive index fu | Sep 22, 2026 |
| LXRX | INST-CLUSTER | bearish | 4/10 | A mixed institutional cluster in LXRX shows 14 buyers adding $60.6M in new positions (dominated by mega-passive funds Bl | Sep 22, 2026 |
| CING | INST-CLUSTER | neutral | 3/10 | A cluster of 9 institutional investors accumulated $2.3M in Cingulate Inc. during Q2 2026, while only one firm trimmed. | Sep 22, 2026 |
| LNZA | INST-CLUSTER | neutral | 3/10 | Eight institutional investors, predominantly mega-passive index funds, accumulated $3.3M in net new LanzaTech positions | Sep 22, 2026 |
| ALTO | INST-CLUSTER | bearish | 4/10 | A mixed institutional cluster in ALTO shows 22 buyers accumulating $20.0M in new positions (dominated by passive/index f | Sep 22, 2026 |
| ONC | INST-CLUSTER | mixed | 4/10 | In Q2 2026, 30 institutional buyers accumulated $372.2M in BeOne Medicines (ONC) while 16 sellers reduced holdings by $4 | Sep 22, 2026 |
| BCAX | INST-CLUSTER | bullish | 4/10 | A large institutional cluster in BCAX shows 36 buyers adding $113.7M in new positions vs 7 sellers reducing $41.8M, a ne | Sep 22, 2026 |
| IPSC | INST-CLUSTER | neutral | 3/10 | A large institutional cluster of 17 buyers (net +$10.4M) versus 4 sellers (-$559K) in Century Therapeutics during Q2 202 | Sep 22, 2026 |
| CLDX | INST-CLUSTER | bullish | 4/10 | A strong institutional cluster emerged in CLDX during Q2 2026, with 31 buyers accumulating $175.2M in net new positions | Sep 22, 2026 |
| AKBA | INST-CLUSTER | mixed | 3/10 | In Q2 2026, 27 institutional buyers accumulated $1.7M in net new Akebia Therapeutics positions, while 13 sellers reduced | Sep 22, 2026 |
| IRD | INST-CLUSTER | neutral | 3/10 | A large institutional cluster in Opus Genetics (IRD) shows 16 buyers adding $15.6M in new positions versus 3 sellers red | Sep 22, 2026 |
| AMTX | INST-CLUSTER | mixed | 3/10 | Institutional activity in AEMETIS (AMTX) during Q2 2026 was mixed: 10 buyers (net +$5.9M) vs 11 sellers (net -$4.1M). Bu | Sep 22, 2026 |
| GPRE | INST-CLUSTER | mixed | 4/10 | A mixed institutional cluster in GPRE for Q2 2026 shows 27 buyers adding $67.3M in net new positions, led by mega-passiv | Sep 22, 2026 |
| CRBU | INST-CLUSTER | mixed | 3/10 | In Q2 2026, 26 institutional buyers accumulated $10.2M in CRBU (net +$4.7M), while 6 sellers reduced holdings by $5.7M. | Sep 22, 2026 |
| SGMT | INST-CLUSTER | bullish | 4/10 | A strong institutional cluster emerged in SGMT during Q2 2026, with 23 buyers accumulating $22.6M in net new positions v | Sep 22, 2026 |
| CRDF | INST-CLUSTER | bearish | 4/10 | Institutional activity in CRDF during Q2 2026 was sharply divided: 15 buyers added $1.6M in new positions (led by Jane S | Sep 22, 2026 |
| GEVO | INST-CLUSTER | bearish | 4/10 | In Q2 2026, 16 institutions added to GEVO positions (aggregate current value $6.7M, net change -$1.0M) while 12 trimmed | Sep 22, 2026 |
| PALI | INST-CLUSTER | mixed | 4/10 | In Q2 2026, 15 institutional buyers accumulated $43.1M in PALI shares while 9 sellers reduced by $13.2M, resulting in a | Sep 22, 2026 |